Psychotherapy plus antidepressant for panic disorder with or without agoraphobia
Authors:
- Toshi A. FurukawaTFToshi A. Furukawa
- Norio WatanabeNWNorio Watanabe
- Rachel ChurchillRCRachel Churchill
- 1 April 2006
- journal article
- review article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 188 (4) , 305-312
Abstract
Background Relapse rates may be as high as 50% in people with major depressive disorder (MDD) previously treated to remission.Keywords
This publication has 36 references indexed in Scilit:
- Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorderJournal of Affective Disorders, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analysesBMJ, 2003
- Empirically supported treatments for panic disorder: Costs, benefits, and stepped care.Journal of Consulting and Clinical Psychology, 2000
- Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobiaJournal of Anxiety Disorders, 1996
- A meta-analysis of treatment outcome for panic disorderClinical Psychology Review, 1995
- The galway study of panic disorder I:Journal of Affective Disorders, 1992
- Combined pharmacological and behavioral treatment for agoraphobiaBehaviour Research and Therapy, 1985
- Placebo-psychotherapy combinations: Inappropriate representations of psychotherapy in drug-psychotherapy comparative trials.Psychological Bulletin, 1981
- Brief standard self-rating for phobic patientsBehaviour Research and Therapy, 1979